In our cohort, patients with TSC and sporadic LAM had broadly similar LAM symptoms and severity, although there was a significantly higher prevalence of angiomyolipoma and the need for angiomyolipoma intervention either with embolization, surgery or mTOR inhibitors in patients with TSC compared with sporadic LAM. The gene discussed is MTOR; the disease is tuberous sclerosis.